{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:32:48Z","timestamp":1791347568349,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hanmi Pharmaceutical Co., Ltd."},{"name":"Basic Science Research Program through the National Research Foundation of Korea","award":["RS-2023-00219399"],"award-info":[{"award-number":["RS-2023-00219399"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00520-025-09614-3","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:26:34Z","timestamp":1748993194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sarcopenia attenuates the efficacy of PEGylated granulocyte colony-stimulating factor in preventing febrile neutropenia"],"prefix":"10.1007","volume":"33","author":[{"given":"Se-Il","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Je","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"9","key":"9614_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G (2021) Diffuse large B-cell lymphoma. N Engl J Med 384(9):842\u2013858","journal-title":"N Engl J Med"},{"issue":"11","key":"9614_CR2","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/ajh.27075","volume":"98","author":"M Tavakkoli","year":"2023","unstructured":"Tavakkoli M, Barta SK (2023) 2024 update: advances in the risk stratification and management of large B-cell lymphoma. Am J Hematol 98(11):1791\u20131805","journal-title":"Am J Hematol"},{"issue":"3","key":"9614_CR3","first-page":"647","volume":"20","author":"R Pettengell","year":"2012","unstructured":"Pettengell R, Johnsen HE, Lugtenburg PJ, Silvestre AS, Duhrsen U, Rossi FG et al (2012) Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma. Support Care Cancer 20(3):647\u2013652","journal-title":"Support Care Cancer"},{"issue":"11","key":"9614_CR4","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3346\/jkms.2014.29.11.1493","volume":"29","author":"YW Choi","year":"2014","unstructured":"Choi YW, Jeong SH, Ahn MS, Lee HW, Kang SY, Choi JH et al (2014) Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. J Korean Med Sci 29(11):1493\u20131500","journal-title":"J Korean Med Sci"},{"issue":"4","key":"9614_CR5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.4143\/crt.2021.1168","volume":"54","author":"SH Jeong","year":"2022","unstructured":"Jeong SH, Kim SJ, Yoon DH, Park Y, Kang HJ, Koh Y et al (2022) Pegfilgrastim prophylaxis is effective in the prevention of febrile neutropenia and reduces mortality in patients aged >\/= 75 years with diffuse large B-cell lymphoma treated with R-CHOP: a prospective cohort study. Cancer Res Treat 54(4):1268\u20131277","journal-title":"Cancer Res Treat"},{"issue":"11","key":"9614_CR6","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1007\/s00277-023-05411-2","volume":"102","author":"M Kim","year":"2023","unstructured":"Kim M, Ahn Y, Ahn HJ, Ha SH, Oh HS, Song JS et al (2023) Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP. Ann Hematol 102(11):3167\u20133175","journal-title":"Ann Hematol"},{"issue":"12","key":"9614_CR7","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/1042819031000119262","volume":"44","author":"GH Lyman","year":"2003","unstructured":"Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M et al (2003) Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin\u2019s lymphoma receiving CHOP chemotherapy. Leuk Lymphoma 44(12):2069\u20132076","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"9614_CR8","first-page":"43","volume":"32","author":"W Zheng","year":"2023","unstructured":"Zheng W, Chen Z, Zhu S, Cheng L, Hu Y, Yang Y et al (2023) Incidence and risk factors for febrile neutropenia of patients with diffuse large B-cell lymphoma receiving R-CHOP-21 in China. Support Care Cancer 32(1):43","journal-title":"Support Care Cancer"},{"issue":"4","key":"9614_CR9","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.4143\/crt.2021.944","volume":"54","author":"DY Kim","year":"2022","unstructured":"Kim DY, Nam J, Chung JS, Jeon BE, Lee JH, Jo JC et al (2022) Predictive parameters of febrile neutropenia and clinical significance of G-CSF receptor signaling pathway in the development of neutropenia during R-CHOP chemotherapy with prophylactic pegfilgrastim in patients with diffuse large B-cell lymphoma. Cancer Res Treat 54(4):1256\u20131267","journal-title":"Cancer Res Treat"},{"issue":"1","key":"9614_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/hematolrep16010008","volume":"16","author":"M Morimoto","year":"2024","unstructured":"Morimoto M, Yokoya Y, Yoshida K, Kosako H, Hori Y, Mushino T et al (2024) Predictive model for occurrence of febrile neutropenia after chemotherapy in patients with diffuse large B-cell lymphoma: a multicenter, retrospective, observational study. Hematol Rep 16(1):76\u201388","journal-title":"Hematol Rep"},{"issue":"1","key":"9614_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1186\/s12885-023-11590-y","volume":"23","author":"SI Go","year":"2023","unstructured":"Go SI, Choi BH, Park MJ, Park S, Kang MH, Kim HG et al (2023) Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell lymphoma. BMC Cancer 23(1):1071","journal-title":"BMC Cancer"},{"issue":"5","key":"9614_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495","journal-title":"Lancet Oncol"},{"key":"9614_CR13","doi-asserted-by":"publisher","first-page":"816883","DOI":"10.3389\/fnut.2022.816883","volume":"9","author":"XT Xu","year":"2022","unstructured":"Xu XT, He DL, Tian MX, Wu HJ, Jin X (2022) Prognostic value of sarcopenia in patients with diffuse large B-cell lymphoma treated with R-CHOP: a systematic review and meta-analysis. Front Nutr 9:816883","journal-title":"Front Nutr"},{"issue":"10","key":"9614_CR14","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/ajh.24465","volume":"91","author":"DY Xiao","year":"2016","unstructured":"Xiao DY, Luo S, O\u2019Brian K, Ganti A, Riedell P, Sanfilippo KM et al (2016) Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy. Am J Hematol 91(10):1002\u20131007","journal-title":"Am J Hematol"},{"issue":"6","key":"9614_CR15","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/jcsm.12837","volume":"12","author":"SI Go","year":"2021","unstructured":"Go SI, Park MJ, Park S, Kang MH, Kim HG, Kang JH et al (2021) Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma. J Cachexia Sarcopenia Muscle 12(6):2211\u20132219","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"9614_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00277-018-3540-1","volume":"98","author":"SI Go","year":"2019","unstructured":"Go SI, Park S, Kang MH, Kim HG, Kim HR, Lee GW (2019) Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma. Ann Hematol 98(2):401\u2013411","journal-title":"Ann Hematol"},{"issue":"1","key":"9614_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12885-020-06921-2","volume":"20","author":"SI Go","year":"2020","unstructured":"Go SI, Kim HG, Kang MH, Park S, Lee GW (2020) Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma. BMC Cancer 20(1):439","journal-title":"BMC Cancer"},{"issue":"21","key":"9614_CR18","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/1759-7714.15389","volume":"15","author":"SI Go","year":"2024","unstructured":"Go SI, Yang JW, Lee WJ, Jeong EJ, Park S, Lee GW (2024) Lipocalin-2 as a prognostic biomarker and its association with systemic inflammation in small cell lung cancer. Thorac Cancer 15(21):1646\u20131655","journal-title":"Thorac Cancer"},{"issue":"7","key":"9614_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629\u2013635","journal-title":"Lancet Oncol"},{"issue":"29","key":"9614_CR20","doi-asserted-by":"publisher","first-page":"47007","DOI":"10.18632\/oncotarget.16552","volume":"8","author":"SI Go","year":"2017","unstructured":"Go SI, Park MJ, Song HN, Kim HG, Kang MH, Kang JH et al (2017) A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one. Oncotarget 8(29):47007\u201347019","journal-title":"Oncotarget"},{"issue":"3","key":"9614_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1200\/JCO.1998.16.3.1179","volume":"16","author":"EA Engels","year":"1998","unstructured":"Engels EA, Lau J, Barza M (1998) Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 16(3):1179\u20131187","journal-title":"J Clin Oncol"},{"issue":"10","key":"9614_CR22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"KJ Aldred","year":"2014","unstructured":"Aldred KJ, Kerns RJ, Osheroff N (2014) Mechanism of quinolone action and resistance. Biochemistry 53(10):1565\u20131574","journal-title":"Biochemistry"},{"issue":"12","key":"9614_CR23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/BF01975175","volume":"8","author":"JS Wolfson","year":"1989","unstructured":"Wolfson JS (1989) Quinolone antimicrobial agents: adverse effects and bacterial resistance. Eur J Clin Microbiol Infect Dis 8(12):1080\u20131092","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"9614_CR24","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1371\/journal.pbio.0060280","volume":"6","author":"L Dethlefsen","year":"2008","unstructured":"Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6(11):e280","journal-title":"PLoS Biol"},{"key":"9614_CR25","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.2147\/JIR.S313085","volume":"14","author":"YY Chen","year":"2021","unstructured":"Chen YY, Kao TW, Chiu YL, Peng TC, Yang HF, Chen WL (2021) Association between Interleukin-12 and sarcopenia. J Inflamm Res 14:2019\u20132029","journal-title":"J Inflamm Res"},{"issue":"22","key":"9614_CR26","doi-asserted-by":"publisher","first-page":"13471","DOI":"10.18632\/aging.205254","volume":"15","author":"KV Chang","year":"2023","unstructured":"Chang KV, Wu WT, Chen YH, Chen LR, Hsu WH, Lin YL et al (2023) Enhanced serum levels of tumor necrosis factor-alpha, interleukin-1beta, and -6 in sarcopenia: alleviation through exercise and nutrition intervention. Aging (Albany NY) 15(22):13471\u201313485","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"9614_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-023-01365-6","volume":"9","author":"J Wu","year":"2023","unstructured":"Wu J, Lin S, Chen W, Lian G, Wu W, Chen A et al (2023) TNF-alpha contributes to sarcopenia through caspase-8\/caspase-3\/GSDME-mediated pyroptosis. Cell Death Discov 9(1):76","journal-title":"Cell Death Discov"},{"issue":"3","key":"9614_CR28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/ijms23031125","volume":"23","author":"NP Ho","year":"2022","unstructured":"Ho NP, Takizawa H (2022) Inflammation regulates haematopoietic stem cells and their niche. Int J Mol Sci 23(3):1125","journal-title":"Int J Mol Sci"},{"key":"9614_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fimmu.2013.00204","volume":"4","author":"LG Schuettpelz","year":"2013","unstructured":"Schuettpelz LG, Link DC (2013) Regulation of hematopoietic stem cell activity by inflammation. Front Immunol 4:204","journal-title":"Front Immunol"},{"issue":"8","key":"9614_CR30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00018-017-2724-5","volume":"75","author":"Y Chiba","year":"2018","unstructured":"Chiba Y, Mizoguchi I, Hasegawa H, Ohashi M, Orii N, Nagai T et al (2018) Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases. Cell Mol Life Sci 75(8):1363\u20131376","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"9614_CR31","first-page":"581","volume":"28","author":"B Wang","year":"2020","unstructured":"Wang B, Thapa S, Zhou T, Liu H, Li L, Peng G et al (2020) Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia. Support Care Cancer 28(2):581\u2013588","journal-title":"Support Care Cancer"},{"key":"9614_CR32","doi-asserted-by":"publisher","first-page":"1162385","DOI":"10.3389\/fpubh.2023.1162385","volume":"11","author":"B Morawin","year":"2023","unstructured":"Morawin B, Tylutka A, Bielewicz F, Zembron-Lacny A (2023) Diagnostics of inflammaging in relation to sarcopenia. Front Public Health 11:1162385","journal-title":"Front Public Health"},{"issue":"2","key":"9614_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/01635581.2024.2411763","volume":"77","author":"K Amano","year":"2025","unstructured":"Amano K, Dev R, Naito T, Del Fabbro E (2025) International survey on consensus definition on nutrition impact symptoms in patients with cancer. Nutr Cancer 77(2):210\u2013220","journal-title":"Nutr Cancer"},{"issue":"4","key":"9614_CR34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/ncp.11152","volume":"39","author":"JC Lopez-Delgado","year":"2024","unstructured":"Lopez-Delgado JC, Patel JJ, Stoppe C, McClave SA (2024) Considerations for medical nutrition therapy management of the critically ill patient with hematological malignancies: a narrative review. Nutr Clin Pract 39(4):800\u2013814","journal-title":"Nutr Clin Pract"},{"issue":"2","key":"9614_CR35","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.cllc.2016.09.008","volume":"18","author":"B Sjoblom","year":"2017","unstructured":"Sjoblom B, Benth JS, Gronberg BH, Baracos VE, Sawyer MB, Flotten O et al (2017) Drug dose per kilogram lean body mass predicts hematologic toxicity from carboplatin-doublet chemotherapy in advanced non-small-cell lung cancer. Clin Lung Cancer 18(2):e129\u2013e136","journal-title":"Clin Lung Cancer"},{"key":"9614_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jncimonographs\/lgad010","volume":"61","author":"SA Purcell","year":"2023","unstructured":"Purcell SA, Kok DE, Ketterl T, Garcia MB, Joffe L, Brown JC et al (2023) (2023) Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition. J Natl Cancer Inst Monogr 61:3\u201311","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"24","key":"9614_CR37","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","volume":"391","author":"JD Groarke","year":"2024","unstructured":"Groarke JD, Crawford J, Collins SM, Lubaczewski S, Roeland EJ, Naito T et al (2024) Ponsegromab for the Treatment of Cancer Cachexia. N Engl J Med 391(24):2291\u20132303","journal-title":"N Engl J Med"},{"issue":"3","key":"9614_CR38","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cncr.31128","volume":"124","author":"N Katakami","year":"2018","unstructured":"Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K et al (2018) Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer 124(3):606\u2013616","journal-title":"Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09614-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09614-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09614-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:29:29Z","timestamp":1757179769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09614-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["9614"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09614-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval for the study was obtained from the Institutional Review Board of Gyeongsang National University Hospital (Approval Number: GNUH 2022\u201306-021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirement for informed consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"533"}}